Attendance an online digital event on Oct. 17, 2024 entitled “Use of heat therapy for the management of musculoskeletal pain in the community pharmacy: New FIP guidance”. The event was offered by International Pharmaceutical Federation (FIP).

Description: Musculoskeletal (MSK) pain is a prevalent illness that affects millions of people, lowering quality of life and raising healthcare expenses. Community pharmacists serve as the initial point of contact for individuals seeking treatment from MSK discomfort. In honor of Global Day Against Pain, the event highlighted a new FIP guidance aimed at improving MSK pain management in pharmacies.  The recommendation assured the use of heat therapy, both as a single therapy and in conjunction with other therapies. Attendees learned regarding various types and symptoms of MSK pain, how heat therapy works, and how to diagnose and manage patients properly in the pharmacy setting.

Moderator:

- Sherif Guorgui, President, FIP Community Pharmacy Section, Canada

Panellists:

- Nisa Masyitah, FIP Project and Data Support Coordinator International Pharmaceutical Federation (FIP), Indonesia 

- Philip Conaghan, Director, NIHR Leeds Biomedical Research Centre University of Leeds, United Kingdom

- Zanoli Gustavo, Orthopaedic Surgeon Casa Di Cura Santa Maria Maddalena, Occhiobello, Italy

- Opeyemi Babatunde, Senior Lecturer: Evidence Synthesis and Applied Health Research School of Medicine, Primary Care Centre Versus Arthritis Keele University, Keele, Staffordshire, United Kingdom

- Ema Paulino, President National Pharmacy Association (ANF), Portugal